Full-Time

IT Support Engineer

Confirmed live in the last 24 hours

Syndax

Syndax

201-500 employees

Develops therapies for difficult-to-treat cancers

Biotechnology
Healthcare

Compensation Overview

$100k - $110kAnnually

+ Equity Offering + Annual Target Bonuses

Mid, Senior

New York, NY, USA

Requires working from Syndax’s primary New York City office.

Category
Customer Success & Support
IT Support
IT & Security
Required Skills
PowerShell
Microsoft Azure
iOS/Swift
Android Development
Requirements
  • A bachelor’s degree in computer science, Information Technology, or similar.
  • 3-5 years of experience as a Helpdesk Support Specialist. Biotech industry experience a plus!
  • Exceptional interpersonal and communication skills, both written and verbal.
  • Proven ability to problem-solve and perform root-cause analysis.
  • Knowledge of O365, Azure AD, Intune, and Azure Cloud Computing Resources. Knowledge of PowerShell preferred.
  • Experience with Windows OS, desktop applications including Microsoft Office with add-ins, web browsers, development tools and libraries.
  • Familiarity with writing documentation to capture process and technology details for repeatable and verifiable high-quality results.
  • Experience assembling and moving physical computer systems and hardware, replacing/updating peripherals, and connections.
  • Exposure to mobile device management including iOS and Android.
Responsibilities
  • First point of contact for daily operational technology support, including support of laptop computers, tablets, mobile devices, virtual desktops, and SaaS applications for a hybrid work force.
  • Participate in rotating on-call schedule for after-hours support.
  • Troubleshoot technology issues spanning the operating system through desktop & cloud applications.
  • Facilitate onboarding & offboarding, including the deployment of assets via Autopilot and the return of workstations.
  • Effectively triage requests via ticketing system (FreshService) while complying with established SLAs and ensuring customer satisfaction.
  • Develop documentation for various technology tasks and troubleshooting steps.
  • Execute, create, and evolve standardized technology solutions and operating procedures.
  • Collaborate with team members on projects and tasks, as assigned.
  • Maintain security across systems in accordance with defined processes and procedures.

Syndax Pharmaceuticals develops and commercializes therapies specifically for cancer patients, focusing on challenging cases like hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2-) breast cancer. The company conducts research and clinical trials to test the safety and effectiveness of its drugs, aiming to bring them to market after receiving regulatory approval. Syndax's main product, Entinostat, is currently in trials combined with Exemestane for treating HR+, HER2- breast cancer. Unlike many competitors, Syndax targets underserved patient populations and relies on strategic partnerships and public offerings to fund its research and development. The goal is to advance cancer treatment by developing new therapies that address the needs of patients with difficult-to-treat cancers.

Company Stage

IPO

Total Funding

$144.3M

Headquarters

Waltham, Massachusetts

Founded

2005

Growth & Insights
Headcount

6 month growth

30%

1 year growth

51%

2 year growth

151%
Simplify Jobs

Simplify's Take

What believers are saying

  • FDA approval of Revuforj boosts Syndax's market position in leukemia treatment.
  • $350M funding from Royalty Pharma supports R&D and commercialization efforts.
  • Positive data from AUGMENT-101 trial enhances Syndax's credibility in oncology.

What critics are saying

  • Potential fiduciary breaches could lead to legal challenges and affect investor confidence.
  • Competitive pressure from Biomea's covalent menin inhibitor may impact market share.
  • Reliance on clinical trial outcomes poses risk if results don't meet expectations.

What makes Syndax unique

  • Syndax focuses on innovative cancer therapies for difficult-to-treat cancers.
  • The company develops unique drugs like Revuforj, a menin inhibitor for acute leukemia.
  • Syndax's pipeline includes axatilimab, targeting chronic Graft versus Host Disease.

Help us improve and share your feedback! Did you find this helpful?